Physician profile
Stuart J Garner
NPI 1487613741
$3,200.90
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,639 · 2020: $763 · 2021: $491 · 2022: $307.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $964.67 | 2019 | |
| Intuitive Surgical, INC. | $549.83 | 2020-2021 | |
| Glaxosmithkline, LLC. | $488.16 | 2019-2021 | |
| Insmed, INC. | $320.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $198.75 | 2019-2022 | |
| Medtronic, INC. | $148.31 | 2022 | |
| Merck Sharp & Dohme LLC | $134.78 | 2019-2020 | |
| Genentech USA, INC. | $119.34 | 2019 | |
| Pulmonx Corporation | $104.95 | 2020 | |
| Ekos Corporation | $92.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.70 | 2022 | |
| Electromed, INC. | $21.53 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.86 | 2019 | |
| Grifols USA, LLC | $12.33 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.